Wound care research is expanding quickly at St. Luke's. Diabetic foot ulcers, venous leg ulcers, and pressure ulcers are among the most prevalent of chronic wounds. Patients with chronic wounds often develop severe complications, such as infection, that can lead to amputation. The goal for wound care research is to discover methods that will achieve the most expeditious closure of wounds possible. Historically, the use of saline-moistened gauze, silver-impregnated dressings, and collagen dressings were the first-line treatment for chronic wounds, but more recently, advanced wound care research has explored exciting new treatments such as wound modulators, growth factors, and human skin equivalents.
Clinical trials in this research area are offered in St. Luke’s locations in Boise and Meridian.
Research Medical Director
Medical Director – St. Luke’s Wound and Hyperbarics
Wound Care Investigators
If you're interested in wound care research at St. Luke’s, please call our clinical research manager at (208) 706-9081 or send us an email.
- Grafix vs Dermagraft: “A Multicenter, Randomized, Single-Blind Trial comparing the Efficacy of Viable Cryopreserved Placental Membrane to Human Fibroblast-Derived Dermal Substitute for the Treatment of Chronic Diabetic Foot Ulcers”, April 2018.